Stockscreener 앱 받기
5.59
0.18%
-0.010
전일 마감가:
$5.60
열려 있는:
$5.56
하루 거래량:
1,622
Relative Volume:
0.25
시가총액:
$282.22M
수익:
순이익/손실:
주가수익비율:
-
EPS:
-
순현금흐름:
1주 성능:
-2.61%
1개월 성능:
-6.05%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$5.525
$5.80
52주 변동 폭
$5.525
$8.20
Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) Company Profile
명칭
Clinuvel Pharmaceuticals Limited American Depositary Shares
전화
-
주소
-
Compare CUVL vs VRTX, MRNA, REGN, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CUVL
Clinuvel Pharmaceuticals Limited American Depositary Shares
|
5.59 | 282.22M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
510.08 | 129.29B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
225.00 | 89.83B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 76.86B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
825.03 | 51.88B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.76 | 40.67B | 742.00K | -1.37B | -1.07B | -7.0731 |
Clinuvel Pharmaceuticals Limited American Depositary Shares 주식(CUVL)의 최신 뉴스
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion - markets.businessinsider.com
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion - GlobeNewswire
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion - The Manila Times
Clinuvel Pharmaceuticals (ASX:CUV) Releases FY26 Report After Expanding U.S. Market Access - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV): US Expansion Strategy and Nasdaq Listing Transition - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV) Makes U.S. Pivot With Nasdaq Uplisting and Headquarters Shift Plan - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV) Lands on Nasdaq—Could Greater US Exposure Trigger a Powerful New Growth Chapter? - Kalkine
Clinuvel Pharmaceuticals (CUVL) uplifts ADR to Level II ADS - Stock Titan
CLINUVEL Pharmaceuticals Completes Nasdaq Uplift with ADS Trading Launch Under CUVL Ticker - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV) Lands on Nasdaq—Could Its New US Listing Transform Global Investor Interest? - Kalkine
CLINUVEL’s ADS to commence trading on Nasdaq - globenewswire.com
CLINUVEL Pharmaceuticals Launches American Depositary Shares on Nasdaq Global Select Market - Kalkine
Upcoming and recent IPOs – IPOs calendar - Yahoo Finance UK
IPO Calendar for: - Yahoo! Finance Canada
CLINUVEL’s ADS to commence trading on Nasdaq - Yahoo Finance
CLINUVEL expects Nasdaq trading; no new shares proposed - Stock Titan
CLINUVEL ADS to commence trading on Nasdaq - scanx.trade
Clinuvel (ASX:CUV) Eyes Nasdaq: What the 20-F Filing Means for CUV Shareholders - Kalkine
CLVLY SEC FilingsClinuvel Pharmaceuticals Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Clinuvl Phrmaceu (CLVLY) Stock Price, News & Analysis - Stock Titan
Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) 재무 분석
Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.64%
0.29%
자본화:
|
볼륨(24시간):